|
1
|
Browning JD, Szczepaniak LS, Dobbins R, et
al: Prevalence of hepatic steatosis in an urban population in the
United States: Impact of ethnicity. Hepatology. 40:1387–1395. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rodriguez B, Torres DM and Harrison SA:
Physical activity: an essential component of lifestyle modification
in NAFLD. Nat Rev Gastroenterol Hepatol. 9:726–731. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fabbrini E, Sullivan S and Klein S:
Obesity and nonalcoholic fatty liver disease: biochemical,
metabolic, and clinical implications. Hepatology. 51:679–689. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Krawczyk M, Bonfrate L and Portincasa P:
Nonalcoholic fatty liver disease. Best Pract Res Clin
Gastroenterol. 24:695–708. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huang HF, He RH, Sun CC, Zhang Y, Meng QX
and Ma YY: Function of aquaporins in female and male reproductive
systems. Hum Reprod Update. 12:785–795. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu H, Zheng Z and Wintour EM: Aquaporins
and fetal fluid balance. Placenta. 29:840–847. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Maeda N: Implications of aquaglyceroporins
7 and 9 in glycerol metabolism and metabolic syndrome. Mol Aspects
Med. 33:665–675. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Elkjaer M, Vajda Z, Nejsum LN, et al:
Immunolocalization of AQP9 in liver, epididymis, testis, spleen,
and brain. Biochem Biophys Res Commun. 276:1118–1128. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Maeda N, Funahashi T and Shimomura I:
Metabolic impact of adipose and hepatic glycerol channels aquaporin
7 and aquaporin 9. Nat Clin Pract Endocrinol Metab. 4:627–634.
2008.PubMed/NCBI
|
|
10
|
Chalasani N, Younossi Z, Lavine JE, et al:
The diagnosis and management of non-alcoholic fatty liver disease:
practice Guideline by the American Association for the Study of
Liver Diseases, American College of Gastroenterology, and the
American Gastroenterological Association. Hepatology. 55:2005–2023.
2012. View Article : Google Scholar
|
|
11
|
Roberts EA: Pediatric nonalcoholic fatty
liver disease (NAFLD): A ‘growing’ problem? J Hepatol.
46:1133–1142. 2007.
|
|
12
|
Angulo P and Lindor KD: Non-alcoholic
fatty liver disease. J Gastroenterol Hepatol. 17(Suppl): S186–S190.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vernon G, Baranova A and Younossi ZM:
Systematic review: the epidemiology and natural history of
non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
in adults. Aliment Pharmacol Ther. 34:274–285. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tailleux A, Wouters K and Staels B: Roles
of PPARs in NAFLD: potential therapeutic targets. Biochim Biophys
Acta. 1821:809–818. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Day CP and James OF: Steatohepatitis: a
tale of two ‘hits’? Gastroenterology. 114:842–845. 1998.
|
|
16
|
Feldstein AE, Werneburg NW, Canbay A, et
al: Free fatty acids promote hepatic lipotoxicity by stimulating
TNF-alpha expression via a lysosomal pathway. Hepatology.
40:185–194. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Day CP: From fat to inflammation.
Gastroenterology. 130:207–210. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gomes D, Agasse A, Thiebaud P, Delrot S,
Geros H and Chaumont F: Aquaporins are multifunctional water and
solute transporters highly divergent in living organisms. Biochim
Biophys Acta. 1788:1213–1228. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Carbrey JM, Gorelick-Feldman DA, Kozono D,
Praetorius J, Nielsen S and Agre P: Aquaglyceroporin AQP9: solute
permeation and metabolic control of expression in liver. Proc Natl
Acad Sci USA. 100:2945–2950. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hara-Chikuma M and Verkman AS:
Physiological roles of glycerol-transporting aquaporins: the
aquaglyceroporins. Cell Mol Life Sci. 63:1386–1392. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Maeda N, Hibuse T and Funahashi T: Role of
aquaporin-7 and aquaporin-9 in glycerol metabolism; involvement in
obesity. Handb Exp Pharmacol. 190:233–249. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Badaut J, Brunet JF, Guerin C, Regli L and
Pellerin L: Alteration of glucose metabolism in cultured astrocytes
after AQP9-small interference RNA application. Brain Res.
1473:19–24. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hamdi M, Sanchez MA, Beene LC, et al:
Arsenic transport by zebrafish aquaglyceroporins. BMC Mol Biol.
10:1042009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Drobna Z, Walton FS, Paul DS, Xing W,
Thomas DJ and Styblo M: Metabolism of arsenic in human liver: the
role of membrane transporters. Arch Toxicol. 84:3–16. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Leung J, Pang A, Yuen WH, Kwong YL and Tse
EWC: Relationship of expression of aquaglyceroporin 9 with arsenic
uptake and sensitivity in leukemia cells. Blood. 109:740–746. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gao L, Gao Y, Li X, et al: Aquaporins
mediate the chemoresistance of human melanoma cells to arsenite.
Mol Oncol. 6:81–87. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hibuse T, Maeda N, Nagasawa A and
Funahashi T: Aquaporins and glycerol metabolism. Biochim Biophys
Acta. 1758:1004–1011. 2006. View Article : Google Scholar
|
|
28
|
King LS, Kozono D and Agre P: From
structure to disease: the evolving tale of aquaporin biology. Nat
Rev Mol Cell Biol. 5:687–698. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Parekh S and Anania FA: Abnormal lipid and
glucose metabolism in obesity: implications for nonalcoholic fatty
liver disease. Gastroenterology. 132:2191–2207. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shoelson SE, Herrero L and Naaz A:
Obesity, inflammation, and insulin resistance. Gastroenterology.
132:2169–2180. 2007. View Article : Google Scholar : PubMed/NCBI
|
